NYSEAMERICAN:XTNT

Xtant Medical Q3 2026 Earnings Results & Report

Xtant Medical logo
$0.21 -0.01 (-2.82%)
As of 11/20/2026 04:10 PM Eastern

Xtant Medical missed analyst expectations on both earnings and revenue in its Q3 2026 results, released November 16, 2026. The company reported EPS of -$0.03 versus the -$0.0250 consensus estimate, while revenue of $24.29 million fell short of the $25.48 million estimate by $1.19 million.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call
8:30 AM ET

Xtant Medical EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.0250
Beat/Miss
Missed by -$0.0050
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Xtant Medical Revenue Results

Actual Revenue
$24.29 million
Expected Revenue
$25.48 million
Beat/Miss
Missed by -$1.19 million
YoY Revenue Growth
N/A

Xtant Medical Q3 2026 Earnings FAQ

Xtant Medical (NYSEAMERICAN:XTNT) reported earnings of -$0.03 per share for Q3 2026, missing the consensus estimate of -$0.0250. The report was announced on Monday, November 16, 2026.

Xtant Medical reported revenue of $24.29 million for Q3 2026, against a consensus estimate of $25.48 million.

Xtant Medical Earnings Headlines

Xtant Medical Holdings, Inc. Evaluates Strategic Review Process
Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
Xtant Medical (XTNT) Projected to Announce Earnings on Monday
See More Xtant Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Xtant Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xtant Medical and other key companies, straight to your email.

About Xtant Medical

Xtant Medical (NYSEAMERICAN:XTNT) Group, Inc. develops and markets medical products used in spine surgery. Its portfolio includes spinal implant systems and biologic products intended to support bone growth and spinal fusion.

The company serves surgeons and healthcare providers, primarily in the United States, and also reaches select international markets through distribution relationships. Its products are used in procedures to treat spinal conditions and support stabilization or fusion.

Xtant Medical’s business brings together spinal-device and biologics operations, including products developed through acquisitions. The company is headquartered in Belgrade, Montana.

View Xtant Medical Profile